Thursday, 21 May 2015   
21st Congress of the European Association of Hospital Pharmacists (EAHP)
16 - 18 March 2016, Vienna, Austria.
European Association of Hospital Pharmacists (EAHP) is organising the 21st Congress with the theme of 'Hospital pharmacists taking the lead - partnerships and technologies'. The scientific program is well advanced and is relevant for hospital pharmacists dealing with the challenge of rapid technological change in healthcare. The role of the hospital pharmacist is not only to use these new technologies in their own practice but also to influence decision makers, multidisciplinary team members and patients about the appropriate use of these technologies in the medication process.
 
Monday, 18 May 2015   
viomedo Provides Access to Innovative Treatment Methods
Information overload is a common and significant problem with most existing clinical trial search platforms or applications. viomedo makes clinical trial information easily accessible to everybody based on a variety of criteria and by following patient-centric approaches. So far, viomedo online platform aggregates about close to 2.000 clinical trials conducted in Germany. viomedo's founder Alexander Puschilov mentioned: "We are convinced, that everybody has the right to get the best possible therapy! This is why we’ve built viomedo to help patients discover and benefit from innovative treatment methods that were previously accessible only to a few lucky patients."
 
Friday, 08 May 2015   
Novartis lung cancer drug Zykadia® gains EU approval, providing new therapy for certain patients with ALK+ NSCLC
NovartisNovartis announced today that the European Commission has approved Zykadia® (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib[1]. The approval of Zykadia in the European Union (EU) provides patients with advanced ALK+ NSCLC previously treated with crizotinib a new treatment option that specifically targets the genetic makeup of their cancer.
 

Research & Development

viomedo Provides Access to Innovative Treatment Methods

Information overload is a common and significant problem with most existing clinical trial search platforms or applications. viomedo makes clinical...

Join the Largest eHealth Gathering of the Year

11 - 13 May 2015, Riga, Latvia. Part of the European eHealth Community? Don't miss out on the event of...

Pharmaceutical industry regulation undermines NICE drugs appraisal work

Government policies that support UK pharmaceutical science and enhance export income are costing the NHS millions and undermine the National...

Inaccurate reporting jeopardizing clinical trials

The team led by Dr Sheena Cruickshank of the Faculty of Life Sciences and Professor Andy Brass from the School...

More in: Research & Development

Conferences & Events

21st Congress of the European Association of Hospital Pharmacists (EAHP)

16 - 18 March 2016, Vienna, Austria. European Association of Hospital Pharmacists (EAHP) is organising the 21st Congress with the theme of 'Hospital pharmacists taking the lead - partnerships and...

The Countdown to eHealth Week 2015

11 - 13 May 2015, Riga, Latvia. Part of the European eHealth Community? Don't miss out on the event of the year. Join eHealth Week 2015 and embark upon three...

eHealth Week 2015 Matchmaking Event

11 - 13 May 2015, Riga, Latvia. eHealth Week 2015 is offering attendees a Matchmaking Event with the aim of encouraging collaboration and generating meaningful global business opportunities between European...

mHealth Summit Europe 2015 and eHealth Week join forces

11 - 12 May 2015, Riga, Latvia. The mHealth Summit Europe will be back in 2015 as a part of eHealth Week in Riga, Latvia. The Summit will be opening...

European Telemedicine Conference 2014

7 - 8 October 2014, Rome, Italy. The European Telemedicine Conference (ETC) 2014 will combine the efforts of several leading European Healthcare Organisations into one powerful event. The conference will...

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Europe to boost cooperation with international partners on generics

News image

The European Union's decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot(IGDRP). The...

European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014

News image

Thirty-nine medicines for human use were recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared...

EMA publishes 2013 annual report

News image

The European Medicines Agency (EMA) has published today its 2013 annual report. In 2013, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for human use...

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

More in: EMA